| mRNA |
Erlotinib |
UHNBreast |
pan-cancer |
AAC |
-0.38 |
0.2 |
| mRNA |
AZD6244 |
UHNBreast |
pan-cancer |
AAC |
-0.23 |
0.4 |
| mRNA |
BRD-K99584050 |
CTRPv2 |
pan-cancer |
AAC |
-0.098 |
0.06 |
| mRNA |
selumetinib:vorinostat (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.09 |
0.01 |
| mRNA |
Erlotinib |
gCSI |
pan-cancer |
AAC |
-0.089 |
0.2 |
| mRNA |
selumetinib:BRD-A02303741 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.085 |
0.01 |
| mRNA |
selumetinib:piperlongumine (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.084 |
0.02 |
| mRNA |
selumetinib:PLX-4032 (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.08 |
0.02 |
| mRNA |
PD-0325901 |
gCSI |
pan-cancer |
AAC |
-0.078 |
0.2 |
| mRNA |
lapatinib |
gCSI |
pan-cancer |
AAC |
-0.076 |
0.2 |